Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva vs Tarceva + Docetaxel in Squamous NSCLC
NCT01204697Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2010
- Primary completion
- Jul 2014
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer, squamous cell carcinoma (NSCLC), sponsored by Roche. Started Nov 2010; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer, squamous cell carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT01204697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204697.